Image via WikipediaMerck's Cladribine Tablets For Multiple Sclerosis Approved In Australia
Merck KGaA announced that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1). Cladribine Tablets will be registered in Australia under the trade name Movectro®.
"Approval of Cladribine Tablets in Australia is another step forward in...click here to read article
MS could be reversed with existing allergy drug
16 hours ago